Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02416102 · ClinicalTrials.gov registry record · Phase 4
Effect of Losartan on Airway Mucociliary Dysfunction in Patients With COPD and Chronic Bronchitis
A Phase 4 study, sponsored by University of Miami.
- Terminated
- Registry status
- Phase 4
- Development phase
- 31
- Enrollment target
NCT02416102 is a Phase 4 study that was terminated before completion, run by University of Miami. The registered enrollment target is 31 participants.
The verdict
NCT02416102, a Phase 4 study, was terminated before completion, sponsored by University of Miami.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 31 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effect of Losartan on cigarette smoke-induced lung injury in smokers and ex-smokers with and without chronic obstructive pulmonary disease (COPD).
Interventions
- DRUG Losartan 50 mg
- DRUG Losartan 100 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2016-03-31 |
| Est. Completion | 2017-04-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02416102
The ClinicalTrials.gov registry entry for NCT02416102 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Losartan 50 mg is the first listed.
NCT02416102 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02416102 about?
NCT02416102 is a clinical study titled "Effect of Losartan on Airway Mucociliary Dysfunction in Patients With COPD and Chronic Bronchitis". The purpose of this study is to evaluate the effect of Losartan on cigarette smoke-induced lung injury in smokers and ex-smokers with and without chronic obstructive pulmonary disease (COPD).
What is the current status of trial NCT02416102?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 31 participants. The study started on 2016-03-31. Estimated completion is 2017-04-03.
What interventions are being tested in trial NCT02416102?
The interventions under investigation include: Losartan 50 mg (DRUG), Losartan 100 mg (DRUG).
Who is sponsoring clinical trial NCT02416102?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.